letrozole has been researched along with ganirelix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chan, C; Liu, K; Russo, M | 1 |
1 review(s) available for letrozole and ganirelix
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for letrozole and ganirelix
| Article | Year |
|---|---|
Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Buserelin; Chorionic Gonadotropin; Cryopreservation; Female; Fertility Agents, Female; Fertility Preservation; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Letrozole; Luteal Phase; Luteinizing Hormone; Oocyte Retrieval; Ovulation Induction; Progesterone; Recombinant Proteins; Treatment Failure; Triple Negative Breast Neoplasms | 2020 |